Published in Cancer Med on June 03, 2012
Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review). Int J Oncol (2014) 1.06
Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer (2014) 0.98
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? Br J Cancer (2013) 0.91
Human papillomavirus and tonsillar and base of tongue cancer. Viruses (2015) 0.86
HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome. PLoS One (2013) 0.84
Epidemiology and survival of HPV-related tonsillar carcinoma. Cancer Med (2014) 0.84
Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival. Cancer Med (2013) 0.84
High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. Cancer Med (2013) 0.82
Distinct patterns of infiltrating CD8+ T cells in HPV+ and CD68 macrophages in HPV- oropharyngeal squamous cell carcinomas are associated with better clinical outcome but PD-L1 expression is not prognostic. Oncotarget (2017) 0.78
Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer. Mol Clin Oncol (2016) 0.78
[HPV-associated oropharyngeal carcinoma. Status quo and relationship with cancer of unknown primary]. Pathologe (2014) 0.77
FOXP3 subcellular localization predicts recurrence in oral squamous cell carcinoma. PLoS One (2013) 0.77
Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.76
Outcome and prognostic factors in T4a oropharyngeal carcinoma, including the role of HPV infection. Biomed Res Int (2014) 0.75
Human papillomavirus infection in 674 Chinese patients with laryngeal squamous cell carcinoma. PLoS One (2014) 0.75
Targeted sequencing of tonsillar and base of tongue cancer and human papillomavirus positive unknown primary of the head and neck reveals prognostic effects of mutated FGFR3. Oncotarget (2017) 0.75
Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol (2006) 5.86
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50
A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29
Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (2007) 4.20
Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol (2004) 2.59
Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer (2001) 2.35
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol (2003) 2.26
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer (2003) 2.24
Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 2.17
Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer (2001) 1.85
Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis (2010) 1.85
The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer (2010) 1.69
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer (2010) 1.57
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55
The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol (2007) 1.49
Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer (2004) 1.40
p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer (2010) 1.34
The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome. Radiother Oncol (2010) 1.31
Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett (2005) 1.22
P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res (2005) 1.22
Expression of p16 protein is associated with human papillomavirus status in tonsillar carcinomas and has implications on survival. Adv Otorhinolaryngol (2005) 1.16
Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer (2010) 1.16
Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res (2004) 0.88
Differential survival trends for patients with tonsillar, base of tongue and tongue cancer in Sweden. Oral Oncol (2011) 0.83
Identification of a third human polyomavirus. J Virol (2007) 7.06
Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27
Oropharyngeal cancer epidemic and human papillomavirus. Emerg Infect Dis (2010) 1.85
The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer (2010) 1.69
Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer (2002) 1.66
The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol (2007) 1.49
[Human papillomavirus important factor in the increased incidence of tonsillar cancer]. Lakartidningen (2006) 1.40
Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients. Int J Cancer (2004) 1.40
KI, WU and Merkel cell polyomaviruses: a new era for human polyomavirus research. Semin Cancer Biol (2009) 1.37
An epidemic of oropharyngeal squamous cell carcinoma (OSCC) due to human papillomavirus (HPV) infection and aspects of treatment and prevention. Anticancer Res (2011) 1.27
P16(INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res (2005) 1.22
Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One (2012) 1.21
Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int J Cancer (2003) 1.17
Human papillomavirus and survival in patients with base of tongue cancer. Int J Cancer (2010) 1.16
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica (2006) 1.15
Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg Infect Dis (2012) 1.03
A related donor and reduced intensity conditioning reduces the risk of development of BK virus-positive haemorrhagic cystitis in allogeneic haematopoetic stem cell-transplanted patients. Anticancer Res (2006) 0.98
DNA from BK virus and JC virus and from KI, WU, and MC polyomaviruses as well as from simian virus 40 is not detected in non-UV-light-associated primary malignant melanomas of mucous membranes. J Clin Microbiol (2008) 0.98
BK virus (BKV) quantification in urine samples of bone marrow transplanted patients is helpful for diagnosis of hemorrhagic cystitis, although wide individual variations exist. J Clin Virol (2003) 0.97
A single vaccination with polyomavirus VP1/VP2Her2 virus-like particles prevents outgrowth of HER-2/neu-expressing tumors. Cancer Res (2005) 0.97
A single-tube, real-time PCR assay for detection of the two newly characterized human KI and WU polyomaviruses. J Clin Virol (2008) 0.96
Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells. Mol Cancer Res (2012) 0.96
Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol (2007) 0.95
Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol (2009) 0.95
Voice handicap and health-related quality of life in laryngectomees: assessments with the use of VHI and EORTC questionnaires. Folia Phoniatr Logop (2009) 0.95
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer. Expert Opin Biol Ther (2007) 0.93
Impact of HPV in Oropharyngeal Cancer. J Oncol (2010) 0.93
MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome. Int J Cancer (2012) 0.93
EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer (2009) 0.93
Human papillomavirus frequency in oral and oropharyngeal cancer in Greece. Anticancer Res (2008) 0.91
Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res (2012) 0.91
Human polyomavirus DNA is not detected in Guthrie cards (dried blood spots) from children who developed acute lymphoblastic leukemia. Med Pediatr Oncol (2003) 0.91
Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden. Scand J Infect Dis (2010) 0.90
Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PLoS One (2012) 0.90
Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer. Anticancer Res (2008) 0.90
Expression of Ku86 confers favorable outcome of tonsillar carcinoma treated with radiotherapy. Head Neck (2003) 0.90
Survival in patients with human papillomavirus positive tonsillar cancer in relation to treatment. Int J Cancer (2011) 0.89
Presence of human papillomavirus in tonsillar cancer is a favourable prognostic factor for clinical outcome. Anticancer Res (2004) 0.88
Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes. Anticancer Res (2006) 0.87
Sexual experiences in relation to HPV vaccination status in female high school students in Sweden. Eur J Contracept Reprod Health Care (2014) 0.86
Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor. Cancer Immunol Immunother (2007) 0.86
Presence and influence of human papillomaviruses (HPV) in Tonsillar cancer. Adv Cancer Res (2005) 0.86
Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome. Cancer Med (2014) 0.86
Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination. Infect Dis (Lond) (2014) 0.85
Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival. Cancer Med (2013) 0.84
Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development. Semin Cancer Biol (2009) 0.84
HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome. PLoS One (2013) 0.84
Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes. Acta Oncol (2005) 0.84